Clinical characteristics, outcomes and regional variations of acquired valvular heart disease patients undergoing cardiac surgery in China

[1] Coffey S(2021)Global epidemiology of valvular heart disease Nat Rev Cardiol 4 342-352

[2] Roberts-Thomson R(2019)Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 global burden of disease study JAMA Cardiol 43 716-799

[3] Brown A(2022)European Society of Cardiology: cardiovascular disease statistics 2021 Eur Heart J 111 1770-1780

[4] Carapetis J(2021)STS adult cardiac surgery database: 2021 update on outcomes, quality, and research Ann Thorac Surg 30 962-970

[5] Chen M(2020)Dismal outcomes and high societal burden of mitral valve regurgitation in France in the recent era: a nationwide perspective J Am Heart Assoc 107 1336-1343

[6] Enriquez-Sarano M(2021)Persisting burden and challenges of rheumatic heart disease Eur Heart J 5 214-221

[7] Zühlke L(2014)Epidemiology of acquired valvular heart disease Can J Cardiol 101 1514-1520

[8] Prendergast BD(2021)Survival of people with valvular heart disease in a large, English community-based cohort study Heart (British Cardiac Society) 113 1683-1692

[9] Liu S(2011)Regional variation in patient risk factors and mortality after coronary artery bypass grafting Ann Thorac Surg 156 19-26

[10] Li Y(2012)Coronary artery bypass graft: contemporary heart surgery center performance in China Circ Cardiovasc Qual Outcomes 140 1156-1169

[1] Coffey S(2021)Global epidemiology of valvular heart disease Nat Rev Cardiol 4 342-352

[2] Roberts-Thomson R(2019)Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 global burden of disease study JAMA Cardiol 43 716-799

[3] Brown A(2022)European Society of Cardiology: cardiovascular disease statistics 2021 Eur Heart J 111 1770-1780

[4] Carapetis J(2021)STS adult cardiac surgery database: 2021 update on outcomes, quality, and research Ann Thorac Surg 30 962-970

[5] Chen M(2020)Dismal outcomes and high societal burden of mitral valve regurgitation in France in the recent era: a nationwide perspective J Am Heart Assoc 107 1336-1343

[6] Enriquez-Sarano M(2021)Persisting burden and challenges of rheumatic heart disease Eur Heart J 5 214-221

[7] Zühlke L(2014)Epidemiology of acquired valvular heart disease Can J Cardiol 101 1514-1520

[8] Prendergast BD(2021)Survival of people with valvular heart disease in a large, English community-based cohort study Heart (British Cardiac Society) 113 1683-1692

[9] Liu S(2011)Regional variation in patient risk factors and mortality after coronary artery bypass grafting Ann Thorac Surg 156 19-26

[10] Li Y(2012)Coronary artery bypass graft: contemporary heart surgery center performance in China Circ Cardiovasc Qual Outcomes 140 1156-1169